Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).

Cancer causes & control : CCC - 1 Oct 2001

Eerola H, Pukkala E, Pyrhönen S, Blomqvist C, Sankila R, Nevanlinna H

Abstract excerpt

OBJECTIVES: To compare the risk of cancer between BRCA1 or BRCA2 mutation-positive and -negative families. METHODS: We assessed standardized incidence ratios (SIR) in 107 Finnish breast cancer families (12 BRCA1, 11 BRCA2, 84 non-BRCA1/2) with confirmed genealogy. The observed numbers of cancer cases were compared to the expected ones; both numbers were based on the population-based Finnish Cancer Registry....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Finland

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Incidence

Share to Infant

Share to Ovarian Neoplasms

Share to Transcription Factors

Source

Identifiers

PMID: 11562114
DOI: 10.1023/a:1011272919982

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).PMID 11562114Read ↗

Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.Semantic proximity Read ↗

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.Semantic proximity Read ↗

Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.Semantic proximity Read ↗

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.Semantic proximity Read ↗

Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer.Semantic proximity Read ↗

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.Semantic proximity Read ↗

A cohort study of reproductive factors and family history of breast cancer in southern Sweden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.